Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Health and health needs of migrants in detention in Greece: shedding light to an unknown reality.

Souliotis K, Saridi M, Banou K, Golna C, Paraskevis D, Hatzakis A, Smith A.

Global Health. 2019 Jan 8;15(1):4. doi: 10.1186/s12992-018-0448-4.

2.

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors.

Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N, Meyer L, Zangerle R, Gill J, Prins M, d'Arminio Montforte A, Kran AB, Porter K, Touloumi G; CASCADE collaboration of EuroCoord.

BMC Med. 2019 Jan 8;17(1):4. doi: 10.1186/s12916-018-1241-1.

3.

Global molecular epidemiology of HIV-1: the chameleon challenge.

Paraskevis D, Hatzakis A.

Lancet Infect Dis. 2018 Nov 30. pii: S1473-3099(18)30687-X. doi: 10.1016/S1473-3099(18)30687-X. [Epub ahead of print] No abstract available.

PMID:
30509776
4.

Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.

Soulie C, Santoro MM, Charpentier C, Storto A, Paraskevis D, Di Carlo D, Gennari W, Sterrantino G, Zazzi M, Perno CF, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG.

J Antimicrob Chemother. 2018 Nov 23. doi: 10.1093/jac/dky464. [Epub ahead of print]

PMID:
30476106
5.

Immunomodulatory Function of HBeAg Related to Short-Sighted Evolution, Transmissibility, and Clinical Manifestation of Hepatitis B Virus.

Kramvis A, Kostaki EG, Hatzakis A, Paraskevis D.

Front Microbiol. 2018 Oct 24;9:2521. doi: 10.3389/fmicb.2018.02521. eCollection 2018. Review.

6.

Human Endogenous Retrovirus-K HML-2 integration within RASGRF2 is associated with intravenous drug abuse and modulates transcription in a cell-line model.

Karamitros T, Hurst T, Marchi E, Karamichali E, Georgopoulou U, Mentis A, Riepsaame J, Lin A, Paraskevis D, Hatzakis A, McLauchlan J, Katzourakis A, Magiorkinis G.

Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10434-10439. doi: 10.1073/pnas.1811940115. Epub 2018 Sep 24.

PMID:
30249655
7.

Pockets of HIV Non-infection Within Highly-Infected Risk Networks in Athens, Greece.

Williams LD, Kostaki EG, Pavlitina E, Paraskevis D, Hatzakis A, Schneider J, Smyrnov P, Hadjikou A, Nikolopoulos GK, Psichogiou M, Friedman SR.

Front Microbiol. 2018 Aug 24;9:1825. doi: 10.3389/fmicb.2018.01825. eCollection 2018.

8.

An Innovative Study Design to Assess the Community Effect of Interventions to Mitigate HIV Epidemics Using Transmission-Chain Phylodynamics.

Magiorkinis G, Karamitros T, Vasylyeva TI, Williams LD, Mbisa JL, Hatzakis A, Paraskevis D, Friedman SR.

Am J Epidemiol. 2018 Dec 1;187(12):2615-2622. doi: 10.1093/aje/kwy160.

PMID:
30101288
9.

Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach.

Kostaki EG, Karamitros T, Stefanou G, Mamais I, Angelis K, Hatzakis A, Kramvis A, Paraskevis D.

Elife. 2018 Aug 7;7. pii: e36709. doi: 10.7554/eLife.36709.

10.

A Network Intervention to Locate Newly HIV Infected Persons Within MSM Networks in Chicago.

Morgan E, Skaathun B, Nikolopoulos GK, Paraskevis D, Williams LD, Smyrnov P, Friedman SR, Schneider JA.

AIDS Behav. 2018 Jun 27. doi: 10.1007/s10461-018-2202-6. [Epub ahead of print]

PMID:
29951972
11.

Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics.

Friedman SR, Williams L, Young AM, Teubl J, Paraskevis D, Kostaki E, Latkin C, German D, Mateu-Gelabert P, Guarino H, Vasylyeva TI, Skaathun B, Schneider J, Korobchuk A, Smyrnov P, Nikolopoulos G.

Curr HIV/AIDS Rep. 2018 Jun;15(3):283-292. doi: 10.1007/s11904-018-0403-2. Review.

PMID:
29905915
12.

Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.

Colagrossi L, Hermans LE, Salpini R, Di Carlo D, Pas SD, Alvarez M, Ben-Ari Z, Boland G, Bruzzone B, Coppola N, Seguin-Devaux C, Dyda T, Garcia F, Kaiser R, Köse S, Krarup H, Lazarevic I, Lunar MM, Maylin S, Micheli V, Mor O, Paraschiv S, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Simon F, Stanojevic M, Stene-Johansen K, Tihic N, Trimoulet P, Verheyen J, Vince A, Lepej SZ, Weis N, Yalcinkaya T, Boucher CAB, Wensing AMJ, Perno CF, Svicher V; HEPVIR working group of the European Society for translational antiviral research (ESAR).

BMC Infect Dis. 2018 Jun 1;18(1):251. doi: 10.1186/s12879-018-3161-2.

13.

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Karamitros T, Papatheodoridis G, Paraskevis D, Hatzakis A, Mbisa JL, Georgopoulou U, Klenerman P, Magiorkinis G.

Front Immunol. 2018 Apr 16;9:777. doi: 10.3389/fimmu.2018.00777. eCollection 2018.

14.

Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links.

Kostaki EG, Nikolopoulos GK, Pavlitina E, Williams L, Magiorkinis G, Schneider J, Skaathun B, Morgan E, Psichogiou M, Daikos GL, Sypsa V, Smyrnov P, Korobchuk A, Malliori M, Hatzakis A, Friedman SR, Paraskevis D.

J Infect Dis. 2018 Jul 24;218(5):707-715. doi: 10.1093/infdis/jiy239.

PMID:
29697829
15.

HIV-1 transmission networks across Cyprus (2010-2012).

Kostrikis LG, Hezka J, Stylianou DC, Kostaki E, Andreou M, Kousiappa I, Paraskevis D, Demetriades I.

PLoS One. 2018 Apr 23;13(4):e0195660. doi: 10.1371/journal.pone.0195660. eCollection 2018.

16.

Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.

Paraskevis D, Nikolopoulos GK, Sypsa V, Psichogiou M, Pantavou K, Kostaki E, Karamitros T, Paraskeva D, Schneider J, Malliori M, Friedman SR, Des Jarlais DC, Daikos GL, Hatzakis A.

Infect Genet Evol. 2018 Aug;62:11-16. doi: 10.1016/j.meegid.2018.04.010. Epub 2018 Apr 10.

PMID:
29653216
17.

Spatiotemporal Characteristics of the HIV-1 CRF02_AG/CRF63_02A1 Epidemic in Russia and Central Asia.

Kostaki EG, Karamitros T, Bobkova M, Oikonomopoulou M, Magiorkinis G, Garcia F, Hatzakis A, Paraskevis D.

AIDS Res Hum Retroviruses. 2018 May;34(5):415-420. doi: 10.1089/AID.2017.0233. Epub 2018 Apr 5.

PMID:
29455562
18.

Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine.

Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, Babii N, Scherbinska A, Thézé J, Pybus OG, Smyrnov P, Mbisa JL, Paraskevis D, Hatzakis A, Magiorkinis G.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056. doi: 10.1073/pnas.1701447115. Epub 2018 Jan 16.

19.

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.

Adland E, Hill M, Lavandier N, Csala A, Edwards A, Chen F, Radkowski M, Kowalska JD, Paraskevis D, Hatzakis A, Valenzuela-Ponce H, Pfafferott K, Williams I, Pellegrino P, Borrow P, Mori M, Rockstroh J, Prado JG, Mothe B, Dalmau J, Martinez-Picado J, Tudor-Williams G, Frater J, Stryhn A, Buus S, Teran GR, Mallal S, John M, Buchbinder S, Kirk G, Martin J, Michael N, Fellay J, Deeks S, Walker B, Avila-Rios S, Cole D, Brander C, Carrington M, Goulder P.

J Virol. 2018 Jan 30;92(4). pii: e01685-17. doi: 10.1128/JVI.01685-17. Print 2018 Feb 15.

20.

Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four Years.

Kostaki E, Magiorkinis G, Psichogiou M, Flampouris A, Iliopoulos P, Papachristou E, Daikos GL, Bonovas S, Otelea D, Friedman SR, Hatzakis A, Paraskevis D.

Curr HIV Res. 2017;15(6):396-404. doi: 10.2174/1570162X15666171120104048.

PMID:
29165088
21.

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health.

Paraskevis D, Kostaki E, Gargalianos P, Xylomenos G, Lazanas M, Chini M, Skoutelis A, Papastamopoulos V, Paraskeva D, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Genes (Basel). 2017 Nov 13;8(11). pii: E322. doi: 10.3390/genes8110322.

22.

Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.

Lodi S, Günthard HF, Dunn D, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Schneider MP, Egger M, Glass TR, Reiss P, van Sighem A, Boender TS, Phillips AN, Porter K, Hawkins D, Moreno S, Monge S, Paraskevis D, Simeon M, Vourli G, Sabin C, Hernán MA; HIV-CAUSAL Collaboration.

AIDS. 2018 Jan 28;32(3):327-335. doi: 10.1097/QAD.0000000000001692.

23.

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.

Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K; for CASCADE Collaboration in EuroCoord.

AIDS. 2018 Jan 14;32(2):161-169. doi: 10.1097/QAD.0000000000001689.

PMID:
29112061
24.

Investigation of Human Immunodeficiency Virus Outbreaks Among People Who Inject Drugs: Timely Diagnosis and Molecular Surveillance are Crucial.

Paraskevis D.

J Infect Dis. 2017 Nov 27;216(9):1049-1050. doi: 10.1093/infdis/jix308. No abstract available.

PMID:
29029266
25.

Molecular Tracing of the Geographical Origin of Human Immunodeficiency Virus Type 1 Infection and Patterns of Epidemic Spread Among Migrants Who Inject Drugs in Athens.

Paraskevis D, Kostaki E, Nikolopoulos GK, Sypsa V, Psichogiou M, Del Amo J, Hodges-Mameletzis I, Paraskeva D, Skoutelis A, Malliori M, Williams L, Friedman SR, Daikos GL, Hatzakis A.

Clin Infect Dis. 2017 Nov 29;65(12):2078-2084. doi: 10.1093/cid/cix717.

26.

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele.

Panagopoulos P, Maltezos E, Hatzakis A, Paraskevis D.

Pharmgenomics Pers Med. 2017 Jun 20;10:205-208. doi: 10.2147/PGPM.S107152. eCollection 2017. Review.

27.

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

Paraskevis D, Kostaki E, Magiorkinis G, Gargalianos P, Xylomenos G, Magiorkinis E, Lazanas M, Chini M, Nikolopoulos G, Skoutelis A, Papastamopoulos V, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Oikonomopoulou M, Zavitsanou A, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Infect Genet Evol. 2017 Oct;54:183-191. doi: 10.1016/j.meegid.2017.07.003. Epub 2017 Jul 5.

PMID:
28688977
28.

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Wiessing L, Ferri M, Běláčková V, Carrieri P, Friedman SR, Folch C, Dolan K, Galvin B, Vickerman P, Lazarus JV, Mravčík V, Kretzschmar M, Sypsa V, Sarasa-Renedo A, Uusküla A, Paraskevis D, Mendão L, Rossi D, van Gelder N, Mitcheson L, Paoli L, Gomez CD, Milhet M, Dascalu N, Knight J, Hay G, Kalamara E, Simon R; EUBEST working group, Comiskey C, Rossi C, Griffiths P.

Harm Reduct J. 2017 Apr 22;14(1):19. doi: 10.1186/s12954-017-0141-6.

29.

Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Micha K, Malliori M, Pharris A, Wiessing L, Donoghoe M, Friedman S, Jarlais DD, Daikos G, Hatzakis A.

J Infect Dis. 2017 May 15;215(10):1496-1505. doi: 10.1093/infdis/jix100.

30.

Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.

Nikolopoulos GK, Christaki E, Paraskevis D, Bonovas S.

Curr Pharm Des. 2017;23(18):2579-2591. doi: 10.2174/1381612823666170329145053. Review.

PMID:
28356043
31.

Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.

Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL.

Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Review.

PMID:
28356041
32.

Erratum to "Editorial for special issue on Evolution of HIV" [Infect. Genet. Evol., Vol. 46, December 2016, pp. 149].

Ayouba A, Paraskevis D, Peeters M.

Infect Genet Evol. 2017 Mar;48:164. doi: 10.1016/j.meegid.2017.01.028. No abstract available.

PMID:
28219520
33.

Re-analysis of unassigned hepatitis C virus (HCV) strain CYHCV025: Evidence of a highly divergent lineage within genotype 1.

Oikonomopoulou M, Demetriou VL, Kostrikis LG, Paraskevis D.

Mol Phylogenet Evol. 2017 Apr;109:362-366. doi: 10.1016/j.ympev.2017.02.003. Epub 2017 Feb 4.

PMID:
28179183
34.

A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP).

Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, Paraskevis D, Sypsa V, Magiorkinis G, Smyrnov P, Korobchuk A, Vasylyeva TI, Skaathun B, Malliori M, Kafetzopoulos E, Hatzakis A, Friedman SR.

Sci Rep. 2016 Dec 5;6:38100. doi: 10.1038/srep38100.

35.

Editorial.

Paraskevis D, Ayouba A, Peeters M.

Infect Genet Evol. 2016 Dec;46:149. doi: 10.1016/j.meegid.2016.11.017. No abstract available. Erratum in: Infect Genet Evol. 2017 Mar;48:164.

PMID:
27914559
36.

Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.

Vasylyeva TI, Friedman SR, Lourenco J, Gupta S, Hatzakis A, Pybus OG, Katzourakis A, Smyrnov P, Karamitros T, Paraskevis D, Magiorkinis G.

AIDS. 2016 Nov 28;30(18):2885-2890.

37.

Primate immunodeficiency virus classification and nomenclature: Review.

Foley BT, Leitner T, Paraskevis D, Peeters M.

Infect Genet Evol. 2016 Dec;46:150-158. doi: 10.1016/j.meegid.2016.10.018. Epub 2016 Oct 24. Review.

38.

Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.

Nikolopoulos GK, Katsoulidou A, Kantzanou M, Rokka C, Tsiara C, Sypsa V, Paraskevis D, Psichogiou M, Friedman S, Hatzakis A.

Epidemiol Infect. 2017 Jan;145(2):401-412. Epub 2016 Oct 26.

PMID:
27780490
39.

HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.

Papachristou E, Tsagkovits A, Zavitsanou A, Hatzakis A, Paraskevis D.

Infect Genet Evol. 2016 Nov;45:415-419. doi: 10.1016/j.meegid.2016.10.003. Epub 2016 Oct 6.

PMID:
27721034
40.

A contaminant-free assessment of Endogenous Retroviral RNA in human plasma.

Karamitros T, Paraskevis D, Hatzakis A, Psichogiou M, Elefsiniotis I, Hurst T, Geretti AM, Beloukas A, Frater J, Klenerman P, Katzourakis A, Magiorkinis G.

Sci Rep. 2016 Sep 19;6:33598. doi: 10.1038/srep33598.

41.

Molecular epidemiology of HIV-1 infection in Europe: An overview.

Beloukas A, Psarris A, Giannelou P, Kostaki E, Hatzakis A, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:180-189. doi: 10.1016/j.meegid.2016.06.033. Epub 2016 Jun 16. Review.

PMID:
27321440
42.

The application of HIV molecular epidemiology to public health.

Paraskevis D, Nikolopoulos GK, Magiorkinis G, Hodges-Mameletzis I, Hatzakis A.

Infect Genet Evol. 2016 Dec;46:159-168. doi: 10.1016/j.meegid.2016.06.021. Epub 2016 Jun 14. Review.

PMID:
27312102
43.

Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Nikolopoulos GK, Kostaki EG, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:256-268. doi: 10.1016/j.meegid.2016.06.017. Epub 2016 Jun 7. Review.

44.

The global spread of HIV-1 subtype B epidemic.

Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, Hamouda O, Struck D, Vercauteren J, Wensing A, Alexiev I, Åsjö B, Balotta C, Gomes P, Camacho RJ, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kostrikis LG, Lepej SJ, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Staneková D, Stanojevic M, Stylianou DC, Boucher CAB; SPREAD program, Nikolopoulos G, Vasylyeva T, Friedman SR, van de Vijver D, Angarano G, Chaix ML, de Luca A, Korn K, Loveday C, Soriano V, Yerly S, Zazzi M, Vandamme AM, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:169-179. doi: 10.1016/j.meegid.2016.05.041. Epub 2016 Jun 2.

45.

Integrating molecular epidemiology and social network analysis to study infectious diseases: Towards a socio-molecular era for public health.

Vasylyeva TI, Friedman SR, Paraskevis D, Magiorkinis G.

Infect Genet Evol. 2016 Dec;46:248-255. doi: 10.1016/j.meegid.2016.05.042. Epub 2016 Jun 2. Review.

46.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

47.

HBV-DNA levels predict overall mortality in HIV/HBV coinfected individuals.

Nikolopoulos GK, Paraskevis D, Psichogiou M, Hatzakis A.

J Med Virol. 2016 Mar;88(3):466-73. doi: 10.1002/jmv.24357. Epub 2015 Aug 27.

PMID:
26288334
48.

Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest.

Paraskevis D, Paraschiv S, Sypsa V, Nikolopoulos G, Tsiara C, Magiorkinis G, Psichogiou M, Flampouris A, Mardarescu M, Niculescu I, Batan I, Malliori M, Otelea D, Hatzakis A.

Infect Genet Evol. 2015 Oct;35:109-21. doi: 10.1016/j.meegid.2015.08.004. Epub 2015 Aug 4.

PMID:
26247720
49.

Dating the origin of hepatitis B virus reveals higher substitution rate and adaptation on the branch leading to F/H genotypes.

Paraskevis D, Angelis K, Magiorkinis G, Kostaki E, Ho SY, Hatzakis A.

Mol Phylogenet Evol. 2015 Dec;93:44-54. doi: 10.1016/j.ympev.2015.07.010. Epub 2015 Jul 26.

PMID:
26220838
50.

Primary resistance to integrase strand-transfer inhibitors in Europe.

Casadellà M, van Ham PM, Noguera-Julian M, van Kessel A, Pou C, Hofstra LM, Santos JR, Garcia F, Struck D, Alexiev I, Bakken Kran AM, Hoepelman AI, Kostrikis LG, Somogyi S, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Staneková D, Stanojevic M, Van Laethem K, Zidovec Lepej S, Clotet B, Boucher CA, Paredes R, Wensing AM; SPREAD programme.

J Antimicrob Chemother. 2015 Oct;70(10):2885-8. doi: 10.1093/jac/dkv202. Epub 2015 Jul 17.

PMID:
26188038

Supplemental Content

Loading ...
Support Center